SCHEMBL6001166

SCHEMBL6001166

[CH2]COCCc1coc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.44
CA2 P00918 1/20 0.42
CYP11B1 P15538 2/20 0.37
CYP11B2 P19099 2/20 0.37
CYP17A1 P05093 1/20 0.37
CYP19A1 P11511 1/20 0.37
IL4I1 Q96RQ9 1/20 0.37
PSMB8 P28062 3/20 0.36
PSMB5 P28074 3/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2097206 0.83 CA2 (0.45) MAOBCA2CYP11B1CYP11B2CYP17A1
SCHEMBL6992883 0.83 MAOB (0.46) MAOBCA2CYP11B1CYP11B2CYP17A1
SCHEMBL2094752 0.83 MAOB (0.46) MAOBCA2CYP11B1CYP11B2CYP17A1
SCHEMBL7360353 0.80 MAOB (0.50) MAOBCA2CYP11B1CYP11B2CYP17A1
SCHEMBL2094754 0.79 PSMB5 (0.49) MAOBCA2PSMB8PSMB5MAOA
SCHEMBL6002749 0.77 MAOB (0.47) MAOBCA2CYP11B1CYP11B2CYP17A1
SCHEMBL2092249 0.76 MAOB (0.53) MAOBCA2CYP11B1CYP11B2CYP17A1
SCHEMBL2097201 0.75 CA2 (0.44) MAOBCA2PSMB8PSMB5HDAC3
SCHEMBL9481576 0.75 MAOB (0.45) MAOBCA2CYP11B1CYP11B2CYP17A1
SCHEMBL2091111 0.74 MAOB (0.41) MAOBCA2CYP11B1CYP11B2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed